VentriPoint Diagnostics is now ranked among the top 10 undervalued stocks in the Medical Devices & Instruments industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Medical Devices & Instruments: Companies that develop, manufacture, and market medical and surgical equipment and machinery, including orthopedic products, respiratory care equipment, x-ray equipment, laser systems, implants, pacemakers, and other major medical machines and apparatus.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| EVMT | Evome Medical | 0.01 | 0.01 | 0.01 (132.1%) | 362831 | 0.5 | 0.0 | 0.0 |
| PRN | Profound Medical | 6.63 | 10.27 | 3.64 (55.0%) | 11776 | 199.2 | 0.0 | 0.0 |
| THRM | Therma Bright | 0.01 | 0.02 | 0.01 (48.9%) | 1367264 | 6.7 | 0.0 | 0.0 |
| PINK | Perimeter Medical Imaging | 0.43 | 0.54 | 0.11 (24.7%) | 55650 | 31.1 | 0.0 | 0.0 |
| VPT | VentriPoint Diagnostics | 0.13 | 0.15 | 0.02 (16.6%) | 110543 | 19.8 | 0.0 | 0.0 |
| NGMD | NuGen Medical Devices | 0.07 | 0.08 | 0.01 (9.3%) | 191813 | 15.0 | 0.0 | 0.0 |
| ZCT | Zero Candida Technologies | 0.33 | 0.34 | 0.01 (4.0%) | 738 | 6.4 | 0.0 | 0.0 |
| TLT | Theralase Technologies | 0.17 | 0.18 | 0.00 (2.1%) | 56244 | 42.0 | 0.0 | 0.0 |
| FREQ | Frequency Exchange | 0.16 | 0.16 | 0.00 (2.0%) | 542 | 7.1 | 0.0 | 0.0 |
All data provided as of May 19, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
VentriPoint Diagnostics
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
VentriPoint Diagnostics is listed under VPT on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.